OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$1.3T
Holdings
444
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (444 positions)
| Stock | Value |
|---|---|
ELLAUDER EST | $1.5B |
BBIOBRIDGEBIO | $1.5B |
ADCAGREE RLTY | $1.5B |
ONCBEIGENE LT | $1.5B |
ISIIONIS PHAR | $1.5B |
ORICORIC PHARM | $1.5B |
EXREXTRA SPAC | $1.5B |
INFN 3.75 08/01/28INFINERA C | $1.4B |
CROXCROCS INC | $1.4B |
CDLXCARDLYTICS | $1.4B |
KROSKEROS THER | $1.4B |
—INTEGRATED | $1.4B |
TEVATEVA PHARM | $1.4B |
HALOHALOZYME T | $1.4B |
KIDSORTHOPEDIA | $1.4B |
AXSMAXSOME THE | $1.4B |
ALKSALKERMES P | $1.4B |
VERAVERA THERA | $1.4B |
AFWALIGN TECH | $1.4B |
ADSKAUTODESK I | $1.4B |
CRMSALESFORCE | $1.4B |
CATBUSDASTRIA THE | $1.4B |
0J7QIAC INC | $1.3B |
RHRH | $1.3B |
LRMRLARIMAR TH | $1.3B |
OFIXORTHOFIX M | $1.3B |
—LONGBOARD | $1.3B |
VSTMVERASTEM I | $1.3B |
ITCIEURINTRA-CELL | $1.3B |
TMCITREACE MED | $1.3B |
CRNXCRINETICS | $1.3B |
CAPRCAPRICOR T | $1.3B |
GTYGETTY RLTY | $1.3B |
PLDPROLOGIS I | $1.2B |
AEOAMERICAN E | $1.2B |
IFRXINFLARX NV | $1.2B |
ALCALCON AG | $1.2B |
RAREULTRAGENYX | $1.2B |
INZYINOZYME PH | $1.2B |
STROSUTRO BIOP | $1.2B |
PTCTPTC THERAP | $1.2B |
ESTAESTABLISHM | $1.2B |
ADIANALOG DEV | $1.2B |
SNOWSNOWFLAKE | $1.1B |
AVBAVALONBAY | $1.1B |
IQVIQVIA HLDG | $1.1B |
IMCRIMMUNOCORE | $1.1B |
—ALCHEMY IN | $1.1B |
APLEAPPLE HOSP | $1.1B |
ARGXARGENX SE | $1.1B |
—MERSANA TH | $1.1B |
HYACHAYMAKER A | $1.1B |
IOVAIOVANCE BI | $1.1B |
AFYAAFYA LTD | $1.0B |
ASNSUSDX4 PHARMAC | $1.0B |
FNAUSDPARAGON 28 | $1.0B |
NVNOENVVENO ME | $994.7M |
KPTIEURKARYOPHARM | $992.8M |
COLDAMERICOLD | $989.9M |
QUREUNIQURE NV | $977.2M |
PECOPHILLIPS E | $977.0M |
AGIOAGIOS PHAR | $974.7M |
MNDYMONDAY COM | $972.2M |
AURAAURA BIOSC | $952.5M |
PLRXPLIANT THE | $951.6M |
PKSTPEAKSTONE | $947.7M |
CATXPERSPECTIV | $946.8M |
PODDINSULET CO | $935.9M |
LIONLIONSGATE | $935.0M |
KALAKALA BIO I | $927.2M |
ATECALPHATEC H | $918.1M |
COOCOOPER COS | $914.3M |
SWTXSPRINGWORK | $913.6M |
TGTXTG THERAPE | $905.1M |
DNLIDENALI THE | $895.6M |
SLNOSOLENO THE | $892.8M |
ARQTARCUTIS BI | $855.8M |
ADPTADAPTIVE B | $846.2M |
PTONPELOTON IN | $845.1M |
SYRSSYROS PHAR | $837.5M |
BCYCBICYCLE TH | $824.6M |
SLRNACELYRIN I | $807.2M |
MLTXMOONLAKE I | $806.7M |
RLAYRELAY THER | $805.8M |
SPYSPDR S&P 5 | $798.5M |
GPCRSTRUCTURE | $790.0M |
VKTXVIKING THE | $784.4M |
CGEMCULLINAN T | $769.6M |
DHID R HORTON | $758.9M |
BLCOBAUSCH PLU | $752.3M |
OVIDOVID THERA | $741.4M |
ARVNARVINAS IN | $740.9M |
ONON SEMICON | $726.1M |
CNTBCONNECT BI | $725.2M |
IRONDISC MEDIC | $721.5M |
MRVLMARVELL TE | $721.2M |
THRDTHIRD HARM | $708.6M |
SPKLSPARK I AC | $701.7M |
DYNDYNE THERA | $693.9M |
DRHDIAMONDROC | $689.7M |